Skip to Main Content
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Advancing Therapy in Suboptimally Controlled Basal Insulin–Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial 

Julio Rosenstock 
ORCHID logo
 ;
Rifat Emral;
Leobardo Sauque-Reyna;
Viswanathan Mohan;
Carlos Trescolí;
Saud Al Sifri;
Nebojsa Lalic;
Agustina Alvarez;
Pascaline Picard;
Mireille Bonnemaire;
Nacima Demil;
Rory J. McCrimmon on behalf of the SoliMix Trial Investigators

 

 
 
 
 

Diabetes Care 2021;44(10):2361–2370

https://doi.org/10.2337/dc21-0393

 

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report
Summary of Revisions: Standards of Care in Diabetes—2025
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
  • Online ISSN 1935-5548
  • Print ISSN 0149-5992

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept